CLINICAL_TRIALS
trial_result
· 2023-09-28
Clinical Trial Update: Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis [Phase 2]
Summary
Phase 2 clinical trial update for ATI-1777 in adults with moderate to severe atopic dermatitis completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aclaris Therapeutics, Inc. | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2023-09-28